Large submacular hemorrhages after verteporfin therapy

American Journal of Ophthalmology

Volumn 137, Issue 3, 2004, Pages 558-560

  Do, Diana V ^a   Bressler, Neil M ^a   Bressler, Susan B ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BENZOPORPHYRIN DERIVATIVE; CLOPIDOGREL; TICLOPIDINE; WARFARIN;

ADULT; AGED; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; RETROSPECTIVE STUDY; REVIEW; SUBMACULA HEMORRHAGE; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 1542357291     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2003.08.001     Document Type: Article

References (1)

1. Verteporfin in Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration two-year results of randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 131:2001;541-560.